Indication
Agammaglobulinemia
Agammaglobulinemia is a rare primary humoral immunodeficiency disorder characterized by an early developmental arrest in B-cell maturation within the bone marrow. Read more about Agammaglobulinemia
42 drugs 16 manufacturers
Drugs that treat it
Common Agammaglobulinemia therapies.
GAMMAPLEX (immune globulin,gamm(IgG)/sorbitol/glycin/IgA 0 to 50 mcg/mL)
BIVIGAM (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
CUVITRU (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
XEMBIFY (immune globulin,gamma (IgG)-klhw human)
BIVIGAM (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD S-D (IGA < 1 MCG/ML) (immune globulin,gamm(IgG)/glycine/glucose/IgA 0 to 50 mcg/mL)
GAMMAPLEX (WITH SORBITOL) (immune globulin,gamm(IgG)/sorbitol/glycin/IgA 0 to 50 mcg/mL)
OCTAGAM (immune globulin,gamm(IgG)/maltose/IgA greater than 50 mcg/mL)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAgammaglobulinemia is a rare primary humoral immunodeficiency disorder characterized by an early developmental arrest in B-cell maturation within the bone marrow.
This disruption leads to an absence or profound deficiency of mature circulating peripheral B cells and a marked reduction across all major serum immunoglobulin isotypes.
Primarily manifesting in infancy or early childhood following the decay of maternal antibodies, the condition leaves patients vulnerable to recurrent, severe sinopulmonary and systemic infections caused predominantly by encapsulated bacteria and certain enteroviruses.
The disease occurs most frequently as an X-linked recessive trait, although various autosomal recessive and dominant forms have also been identified.
- nih.gov
Agammaglobulinemia is a rare primary humoral immunodeficiency disorder characterized by an early developmental arrest in B-cell maturation within the bone marrow This disruption leads to an absence or profound deficiency of mature circulating peripheral B cells and a marked reduction across all major serum immunoglobulin isotypes Primarily manifesting in infancy or early childhood following the decay of maternal antibodies, the condition leaves patients vulnerable to recurrent, severe sinopulmon...
- nih.gov
Agammaglobulinemia is a rare primary humoral immunodeficiency disorder characterized by an early developmental arrest in B-cell maturation within the bone marrow The disease occurs most frequently as an X-linked recessive trait, although various autosomal recessive and dominant forms have also been identified
- nih.gov
This disruption leads to an absence or profound deficiency of mature circulating peripheral B cells and a marked reduction across all major serum immunoglobulin isotypes The disease occurs most frequently as an X-linked recessive trait, although various autosomal recessive and dominant forms have also been identified
- medlineplus.gov
Primarily manifesting in infancy or early childhood following the decay of maternal antibodies, the condition leaves patients vulnerable to recurrent, severe sinopulmonary and systemic infections caused predominantly by encapsulated bacteria and certain enteroviruses
Personalize your experience
Follow Agammaglobulinemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.